BNET Industries
Market Cap:$232.8M
Last Fiscal Year Sales:$130.2M
- Public
- US
Dow Jones Description
To become a leading specialty pharmaceutical company that acquires, develops and commercializes proprietary products that address the needs of patients treated by gastroenterologists or primary care physicians.
Number of Employees 345
Peer Companies
NAICS Code Pharmaceutical Preparation Manufacturing: 325412
Recent Events
-
HEADLINE STOCKS-U.S. small/midcap stocks on the move on Nov 5
-
Santarus Inc executes licence agreement for ZEGERID products in Europe
-
Santarus Reports Second Quarter 2009 Financial Results
News & Analysis
Filter by
commercialization and santarus inc. - All News and Analysis
Santarus Names New CEO; Specialty Pharmaceutical Company Presents At JPMorgan H&Q Annual Healthcare Conference on January 9
- 2002-01-10
Business Editors & Health/Medical Writers BIOWIRE2K SAN DIEGO--BW HealthWire--Jan. 7, 2002 Santarus, Inc., a specialty pharmaceutical company focused on diseases related to gastroenterology, announced today it has promoted Gerald T. Proehl from president and chief operating officer to president and chief executive officer. Previous CEO Kenneth Widder,...
Santarus Names New CEO; Specialty Pharmaceutical Company Presents At JPMorgan H&Q Annual Healthcare Conference on January 9
- 2002-01-07
Business Editors & Health/Medical Writers BIOWIRE2K SAN DIEGO--BW HealthWire--Jan. 7, 2002 Santarus, Inc., a specialty pharmaceutical company focused on diseases related to gastroenterology, announced today it has promoted Gerald T. Proehl from president and chief operating officer to president and chief executive officer. Previous CEO Kenneth Widder,...
Santarus, Inc. to Present At UBS Warburg Global Life Sciences Conference; Company Also Announces Continued Expansion With Recent In-Licensing and Two New Personnel Appointments
- 2001-10-05
Business Editors & Health/Medical Writers BIOWIRE2K SAN DIEGO--BW HealthWire--Oct. 5, 2001 Santarus, Inc., a specialty pharmaceutical company focused on diseases related to gastroenterology, announced today it will participate in the UBS Warburg Global Life Sciences Conference at The Pierre Hotel in New York City on Monday, October...
- 1
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
Glass Door
Pharma Industry Companies
| Company | Employer Rating |
| Johnson & Johnson |  |
| Merck | |
| Pfizer | |
| Novartis |  |
| Abbott Labs | |
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- Teva, In Turnabout, Sues to Protect Its Multiple Sclerosis Drug Copaxone 3 votes
- BioCryst's Antiviral Drug Peramivir Aims to Keep Swine-Flu Body Count Low 3 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes
